Caribou Biosciences to Participate in Upcoming Investor Conferences
BERKELEY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company's
Caribou BiosciencesMay 1 00:00 ET
Lacklustre Performance Is Driving Caribou Biosciences, Inc.'s (NASDAQ:CRBU) 27% Price Drop
Caribou Biosciences, Inc. (NASDAQ:CRBU) shareholders that were waiting for something to happen have been dealt a blow with a 27% share price drop in the last month. The recent drop has obliterated
Simply Wall StApr 25 06:51 ET
Caribou Biosciences to Present Initial Dose Expansion Data From CB-010 ANTLER Phase 1 Trial in R/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
BERKELEY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstract
Caribou BiosciencesApr 24 00:00 ET
Express News | Caribou Biosciences Announces Oral Presentation on in Vivo Cas12a Chrdna Genome Editing at the 27TH Annual Meeting of the American Society of Gene and Cell Therapy (Asgct)
Moomoo 24/7Apr 15 09:00 ET
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a ChRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
BERKELEY, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced an abstract
Caribou BiosciencesApr 15 00:00 ET
Buy Rating Affirmed: Caribou Biosciences' Promising Trials and Strategic Market Positioning
TipRanksApr 8 03:25 ET
Sector Update: Health Care Stocks Lean Higher Pre-Bell Friday
Health care stocks were leaning higher pre-bell Friday, with the Health Care Select Sector SPDR Fund (XLV) up 0.5% and the iShares Biotechnology ETF (IBB) flat recently. Nutex Health (NUTX) shares sli
MT NewswiresApr 5 08:57 ET
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday. Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS) climbed 6% to $110.11 in pre-market trading foll
BenzingaApr 5 08:01 ET
We're Hopeful That Caribou Biosciences (NASDAQ:CRBU) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new tr
Simply Wall StApr 5 06:09 ET
Analysts Offer Insights on Healthcare Companies: 3SBio (OtherTRSBF), UnitedHealth (UNH) and Caribou Biosciences (CRBU)
TipRanksApr 5 05:40 ET
Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)
TipRanksApr 5 05:00 ET
Caribou Biosciences Advances With FDA Clearance and New Trials
TipRanksApr 4 16:24 ET
Caribou Biosciences Expands Clinical Development Of CB-010 With FDA Clearance Of IND In Lupus
-- FDA has cleared Caribou's IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 ---- Driven by encouraging initial safety
BenzingaApr 4 16:01 ET
Biotech Roundtable: Who Will Bring the Next CRISPR Drug to Market?
Seeking AlphaApr 2 11:36 ET
With 65% Institutional Ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) Is a Favorite Amongst the Big Guns
Yahoo FinanceApr 1 06:18 ET
HC Wainwright Adjusts Caribou Biosciences Price Target to $24 From $23, Maintains Buy Rating
Caribou Biosciences (CRBU) has an average rating of Buy and price targets ranging from $10 to $30, according to analysts polled by Capital IQ. Price: 5.4, Change: +0.18, Percent Change: +3.35
MT NewswiresMar 19 09:21 ET
Caribou Biosciences Is Maintained at Buy by HC Wainwright & Co.
Caribou Biosciences Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 19 06:36 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Fusion Pharmaceuticals (FUSN), Caribou Biosciences (CRBU) and Neurogene (NGNE)
TipRanksMar 19 06:30 ET
Express News | HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Raises Price Target to $24
Moomoo 24/7Mar 19 06:26 ET
Caribou Biosciences (NASDAQ:CRBU): Recent Price Volatility May Offer Investors an Entry Point
TipRanksMar 14 14:29 ET
No Data
No Data